Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)
Stefano Durante, Francesco Cuccia, Michele Rigo, Giovanni Caminiti, Federico Mastroleo, Roberta Lazzari, Giulia Corrao, Giuseppe Caruso, S. Vigorito, Federica Cattani, Giuseppe Ferrera, Vito Chiàntera, Filippo Alongi, Nicoletta Colombo, Barbara Alicja Jereczek‐Fossa
Topics & Concepts
MedicineOvarian cancerPoly ADP ribose polymerasePolymeraseRadiation therapyOncologyCancer researchInternal medicineCancerEnzymeBiochemistryChemistryPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments